DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,019,265 | -1.9% | 8,139 | -5.0% | 0.15% | +1.3% |
| Q2 2023 | $2,057,668 | -7.1% | 8,563 | -2.4% | 0.15% | -12.2% |
| Q1 2023 | $2,214,823 | +10.9% | 8,778 | +16.8% | 0.17% | -7.5% |
| Q4 2022 | $1,996,790 | -12.4% | 7,516 | -14.8% | 0.19% | -15.5% |
| Q3 2022 | $2,280,000 | +10.3% | 8,819 | +8.2% | 0.22% | +8.4% |
| Q2 2022 | $2,068,000 | -10.7% | 8,151 | +3.3% | 0.20% | -6.9% |
| Q1 2022 | $2,317,000 | -7.3% | 7,891 | +3.9% | 0.22% | +5.8% |
| Q4 2021 | $2,500,000 | +22.9% | 7,595 | +13.7% | 0.21% | +13.2% |
| Q3 2021 | $2,034,000 | +25.2% | 6,678 | +10.3% | 0.18% | +23.0% |
| Q2 2021 | $1,625,000 | +14.8% | 6,052 | -3.7% | 0.15% | -4.5% |
| Q1 2021 | $1,415,000 | -7.9% | 6,283 | -9.2% | 0.16% | -11.4% |
| Q4 2020 | $1,537,000 | +1.0% | 6,917 | -2.1% | 0.18% | -15.9% |
| Q3 2020 | $1,522,000 | +27.7% | 7,063 | +4.9% | 0.21% | +16.2% |
| Q2 2020 | $1,192,000 | +92.3% | 6,733 | +50.6% | 0.18% | +53.0% |
| Q1 2020 | $620,000 | -7.5% | 4,472 | +2.5% | 0.12% | -2.5% |
| Q4 2019 | $670,000 | +22.3% | 4,361 | +15.0% | 0.12% | +12.1% |
| Q3 2019 | $548,000 | +4.2% | 3,791 | +3.0% | 0.11% | +3.9% |
| Q2 2019 | $526,000 | -38.3% | 3,679 | -42.9% | 0.10% | -38.0% |
| Q1 2019 | $852,000 | +67.4% | 6,447 | +30.9% | 0.17% | +41.9% |
| Q4 2018 | $509,000 | -1.2% | 4,924 | +4.1% | 0.12% | +11.4% |
| Q3 2018 | $515,000 | +6.6% | 4,728 | -3.2% | 0.10% | +2.9% |
| Q2 2018 | $483,000 | -7.5% | 4,885 | -8.3% | 0.10% | -8.1% |
| Q1 2018 | $522,000 | -1.7% | 5,325 | -0.3% | 0.11% | +7.8% |
| Q4 2017 | $531,000 | +14.4% | 5,340 | -1.2% | 0.10% | +6.2% |
| Q3 2017 | $464,000 | +26.4% | 5,404 | +24.6% | 0.10% | +18.3% |
| Q2 2017 | $367,000 | +13.3% | 4,337 | +14.5% | 0.08% | +7.9% |
| Q1 2017 | $324,000 | +6.9% | 3,789 | -2.6% | 0.08% | 0.0% |
| Q4 2016 | $303,000 | -5.3% | 3,892 | -4.7% | 0.08% | +4.1% |
| Q3 2016 | $320,000 | -17.3% | 4,083 | +6.5% | 0.07% | -22.3% |
| Q2 2016 | $387,000 | -0.3% | 3,835 | -6.3% | 0.09% | +2.2% |
| Q1 2016 | $388,000 | +81.3% | 4,094 | +63.7% | 0.09% | -53.1% |
| Q2 2015 | $214,000 | – | 2,501 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |